Randomized Controlled Trial of a Remote Coaching mHealth Adherence Intervention in Youth Living with HIV

AIDS Behav. 2022 Dec;26(12):3897-3913. doi: 10.1007/s10461-022-03717-2. Epub 2022 Jun 7.

Abstract

Youth living with HIV (YLWH) in the US have low rates of viral suppression (VS). In a prospective randomized clinical trial (ATN152) that enrolled 89 YLWH on antiretroviral therapy (ART) with detectable viral load, we evaluated a 12 week triggered escalating real-time adherence (TERA) intervention with remote coaching, electronic dose monitoring (EDM), and outreach for missed/delayed doses compared to standard of care (SOC). Median [Q1, Q3] percent days with EDM opening was higher in TERA (72% (47%, 89%)) versus SOC (41% (21%, 59%); p < 0.001) and incidence of numbers of 7 day gaps between openings were lower (TERA to SOC ratio: 0.40; 95% CI 0.30, 0.53; p < 0.001). There were no differences in VS at week 12 (TERA 35%; 95% CI 21%, 51% versus SOC 36%; 95% CI 22%, 51%; p > 0.99) or later time-points. The intervention improved adherence but not VS in heavily ART-experienced YLWH. Remote coaching more closely tailored to the unique dosing patterns and duration of need for youth struggling to reach VS warrants further investigation.

Keywords: Coaching; EDM; Intervention; Viral suppression; YLWH; Youth; mHealth.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Anti-HIV Agents* / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Medication Adherence
  • Mentoring*
  • Prospective Studies
  • Telemedicine*
  • Viral Load

Substances

  • Anti-HIV Agents